FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

36114511000001106: Verzenios 150mg tablets (Eli Lilly and Company Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
111290801000001112 Verzenios 150mg tablets (Eli Lilly and Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111290901000001118 Verzenios 150mg tablets (Eli Lilly and Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Verzenios 150mg tablets (Eli Lilly and Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Verzenios 150mg tablets (Eli Lilly and Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Verzenios 150mg tablets (Eli Lilly and Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Verzenios 150mg tablets (Eli Lilly and Company Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Verzenios 150mg tablets (Eli Lilly and Company Ltd) Is a Abemaciclib 150mg tablets true Inferred relationship Existential restriction modifier
Verzenios 150mg tablets (Eli Lilly and Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Verzenios 150mg tablets (Eli Lilly and Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Verzenios 150mg tablets (Eli Lilly and Company Ltd) Has specific active ingredient Abemaciclib true Inferred relationship Existential restriction modifier
Verzenios 150mg tablets (Eli Lilly and Company Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Verzenios 150mg tablets (Eli Lilly and Company Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Verzenios 150mg tablets (Eli Lilly and Company Ltd) Is a Verzenios true Inferred relationship Existential restriction modifier
Verzenios 150mg tablets (Eli Lilly and Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Verzenios 150mg tablets (Eli Lilly and Company Ltd) Has active ingredient Abemaciclib true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Verzenios 150mg tablets (Eli Lilly and Company Ltd) 28 tablet 2 x 14 tablets Has AMP True Verzenios 150mg tablets (Eli Lilly and Company Ltd) Inferred relationship Existential restriction modifier
Verzenios 150mg tablets (Eli Lilly and Company Ltd) 56 tablet 4 x 14 tablets Has AMP True Verzenios 150mg tablets (Eli Lilly and Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start